Henoch-Schonlein Purpura
En Español (Spanish Version)

Definition
Henoch-Schonlein purpura (HSP) is inflammation of the blood vessels in the skin and other body organs. When it involves the skin, it causes a telltale rash. The rash looks like bruising or small dots in the skin, referred to as purpura.

Causes
HSP is caused by an abnormal reaction of the immune system. Normally, the immune system marks and attacks foreign items like viruses and bacteria. However, with HSP, the immune system attacks the blood vessels. It is not clear why the immune system attacks the body.

The change in the immune system may be triggered by:

  • Bacterial or viral infections
  • Certain medications
  • Recent exposure to certain vaccines
  • Infection by insect bites
HSP occurs most often after a respiratory infection. HSP is not contagious.

Risk Factors
HSP is most common in children aged 2 to 11 years old, but it can occur at any age. Factors that increase your risk of HSP include:

  • Recent upper respiratory illness, such as a cold
  • Recent exposure to vaccines, chemicals, cold weather, or insect bites
Symptoms
Symptoms may last for 4 to 6 weeks and may include:

  • Skin rash:
    • Reddish-purple spots that can be felt and are not itchy
    • Often appears on the buttocks or legs, may appear on the elbows
    • Red spots of various sizes
    • Bruising, usually below the waist
  • Pain in the joints, especially knees and ankles
  • Abdominal pain
  • Blood in the urine caused by kidney inflammation
  • Swelling of the ankles
  • Swelling of the scrotum in males
  • Fever
  • Blood in the stool
  • Vomiting
Diagnosis
Your doctor will ask about your symptoms and medical history. A physical exam will be done.

Your bodily fluids, tissues, and waste may be tested. This can be done with:

  • Blood tests
  • Urinalysis
  • Stool sample
  • Skin biopsy from an area of the rash
Skin Biopsy

Copyright © Nucleus Medical Media, Inc.
Treatment
HSP usually gets better on its own. Your doctor may prescribe medications if symptoms or complications are causing problems. Medications may include:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs)—to lessen joint pain and arthritis
  • Steroid medication—for significant abdominal pain, joint pain, or kidney disease
  • Antibiotics—to treat bacterial infection
  • Cyclophosphamide (Cytoxan)—to suppress the immune system when you have symptoms of severe kidney disease
Prevention
There are no guidelines to prevent HSP. Relapse occurs in about 50% of cases.

It is important to make sure that you have long-term, follow-up visits with your doctor to be sure that kidney disease doesn't develop.




RESOURCES:
American Academy of Family Physicians

American Autoimmune Related Diseases Association

CANADIAN RESOURCES

College of Family Physicians of Canada

References:
Dillon MJ. Henoch-Schonlein purpura (treatment and outcome). Cleve Clin J Med. 2002;69(Suppl 2):SII121-SII123.

Henoch-Schonlein purpura. National Institute of Diabetes and Digestive and Kidney Disease website. Updated September 7, 2012. Available at: http://familydoctor.org/familydoctor/en/diseases-conditions/henoch-schonlein-purpura.html. Accessed November 13, 2012.

Henoch-Schonlein purpura. National Institute of Health Office of Rare Disease Research website. Available at: http://rarediseases.info.nih.gov/GARD/Condition/8204/HenochSchonlein_purpura.aspx/Print. Accessed August 6, 2013.

Kraft D, McKee D, et al. Henoch-Schonlein purpura: a review. Am Fam Physician. 1998 Aug 1;58(2):405-408. Available at: http://www.aafp.org/afp/1998/0801/p405.html. Accessed November 13, 2012.

Ronkainen J, Koskimies O, et al. Early prednisone therapy in Henoch-Schonlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2006;149:241-247.

Saulsbury FT. Epidemiology of Henoch-Schonlein purpura. Cleve Clin J Med. 2002;69(Suppl 2):SII87-SII89.

Last Reviewed August 2013



Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

 

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

 

To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.